Search NSPR
InspireMD, Inc.
Nasdaq · CIK 1433607
Last close0.62
Daily change+0.00 (0.00%)
10 Years gain-100.00%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
NSPR · STANDARD
SIC 3841 · Surgical & Medical Instruments & Apparatus · Fiscal year end 1231
Fundamental
47.6Momentum
0.0Acceleration
0.0Confidence
75.0Annual Revenue17
Quarterly Revenue59
Annual CFO14
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth23.1 / 25
Quality4.7 / 25
Capital Efficiency2.4 / 20
Balance Sheet15.0 / 15
Shareholder Economics0.0 / 10
Forward Indicators0.0 / 5
Signals
Net debt reductionNet debt declined versus the comparison period.
Warnings
Gross margin compression · MEDIUMGross margin compressed by 9.9216 percentage points.
Operating margin compression · MEDIUMOperating margin compressed by 41.0745 percentage points.
Heavy share dilution · HIGHDiluted share count increased 69.3419%.
ROIC declining · MEDIUMROIC declined by 823.9057 percentage points.
Possible growth trap · HIGHRevenue growth is high, but quality indicators are deteriorating.
Key Metrics
Revenue Growth TTM34.77%OK
Revenue CAGR 3Y20.19%OK
Gross Margin11.51%OK
Operating Margin-575.43%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC-2,570.89%OK
Incremental Operating Margin 3Y-845.75%OK
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y69.34%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $8.98M | $2.65M | -$49.61M | -$35.10M | -$36.77M | 29.5% | -552.56% | -409.46% | -3,214.03% | 64.33M |
| 2025 FY Dec 31, 2024 | $7.01M | $1.51M | -$33.50M | -$21.87M | -$23.27M | 21.49% | -478% | -332% | -2,747% | 41.93M |
| 2024 FY Dec 31, 2023 | $6.21M | $1.81M | -$21.14M | -$16.38M | -$16.76M | 29.12% | -340.74% | -270.06% | -252.33% | 24.27M |
| 2023 FY Dec 31, 2022 | $5.17M | $1.12M | -$18.71M | -$15.54M | -$16.02M | 21.6% | -361.88% | -309.71% | -86.23% | 7.87M |
| 2022 FY Dec 31, 2021 | $4.50M | $754,000.00 | -$14.72M | -$13.21M | -$13.55M | 16.77% | -327.39% | -301.54% | -110.48% | n/a |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $9.47M | sum latest 4 fiscal quarters Revenue | OK | 0001493152-26-038438, 0001493152-25-021503 |
| Revenue Growth TTM | 34.77% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001493152-26-038438, 0001493152-25-021503 |
| Revenue CAGR 3Y | 20.19% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001493152-26-010886 |
| Revenue CAGR 5Y | 29.29% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001493152-26-010886 |
| Gross Profit CAGR 3Y | 33.36% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001493152-26-010886 |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | 0001493152-26-038438, 0001493152-25-021503 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 11.51% | Gross Profit / Revenue | OK | 0001493152-26-038438, 0001493152-25-021503 |
| Operating Margin | -575.43% | Operating Income / Revenue | OK | 0001493152-26-038438, 0001493152-25-021503 |
| ROIC | -2,570.89% | NOPAT / Average Invested Capital | OK | 0001493152-26-038438, 0001493152-25-021503 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001493152-26-038438 |
| Current Ratio | 3.8x | Current Assets / Current Liabilities | OK | derived |
| Revenue per Diluted Share | $0.11 | Revenue / Diluted Shares | OK | 0001493152-26-038438, 0001493152-25-021503 |
| SBC / FCF | n/a | SBC / FCF | NOT_MEANINGFUL | derived |